alluvi350425 - Profile

About me

Profile

Alluvi, known as BI 4744, represents a notable breakthrough in obesity therapy. This dual activator targeting both GLP-1 and GIP receptors demonstrates remarkable results in research studies,

https://alluvi-research.co.uk/